Results showed that high/moderate expression of ANGPTL4 protein, apart from lymph metastasis, was independent factor for predicting an adverse 2-year PFS for ESCC patients (Table 2). This evidence concerns the gene ANGPTL4 and esophageal squamous cell carcinoma.